NPHP4 Deficiency Disrupts Testicular Homeostasis and Impairs Male Fertility in Medaka (Oryzias latipes)

Knocking out a cilia gene in fish collapses the testicular niche — sperm motility fails and Sertoli cells die off before sperm do

Journal: Reproduction | Published: 2026-03-15 | Type: Journal Article (animal study) | PMID: 41782365 Authors: Liang Jingjie et al. — State Key Laboratory of Mariculture Breeding, Jimei University, China Funding/COI: Fujian Provincial Natural Science Foundation of China; Scientific Research Foundation of Jimei University. No COI declared.

Summary

NPHP4 is a nephronophthisis-associated ciliopathy gene known to cause male infertility in some species, but how it does so has been unclear. Using CRISPR/Cas9 knockout in Japanese medaka fish, this team traced the damage upstream: Sertoli cells expressing nphp4 undergo apoptosis early in life, and germ cell depletion follows. By 6 months, mutant fish are functionally infertile, their sperm showing severe motility defects, head abnormalities, and mitochondrial damage despite intact flagella.

Claims

• nphp4 transcripts localize to gsdf-positive Sertoli cells within the spermatogonial niche, not in germ cells directly
• CRISPR knockout produces age-dependent infertility with significant decline in fertilization rates by 6 months
• Sperm flagellar structure remains grossly intact, but motility is severely impaired — suggesting the defect is functional, not structural
• Sperm also exhibit head abnormalities and mitochondrial damage at 6 months
• Somatic cell dysfunction (Sertoli cell apoptosis, altered functional marker expression) precedes germ cell depletion
• Transcriptomic profiling identified disrupted signaling pathways affecting spermatogonial stem cell maintenance, ion homeostasis, cytoskeletal organization, and cell adhesion

Study Quality

This is a mechanistic animal study — not a clinical trial, not a cohort study, not directly applicable to human patients. The experimental toolkit is solid: CRISPR/Cas9 for precise gene disruption, in situ hybridization for spatial localization, and bulk transcriptomics for pathway-level effects. Age-tracking the phenotype (progression from fertile to infertile over months) adds biological depth.

The medaka model is worth scrutinizing. Unlike mammalian testes — where spermatogenesis occurs in tubules with continuous production — medaka use cystic spermatogenesis, where germ cells develop in synchronous cysts. This is a fundamentally different architecture from human testis biology. Results that hold here may or may not reflect the same mechanism in men with NPHP4 mutations.

Red Flags

• Fish model with structurally distinct spermatogenesis — direct translation to human fertility is speculative
• No functional rescue experiment (re-introducing nphp4 to confirm the phenotype is gene-specific, not an off-target CRISPR effect)
• Sample sizes for each experimental condition not reported in the abstract
• No COI statement provided — minor issue given academic funding, but worth noting
• Transcriptomic data is correlational; pathway disruptions are associations, not proven causal chains

Strengths

• Upstream somatic cell characterization is a genuine mechanistic contribution — most infertility studies focus on sperm end-products, not niche collapse
• CRISPR knockout is a clean genetic tool for this kind of functional dissection
• Age-dependent phenotype mirrors the progressive infertility seen clinically in some ciliopathy patients
• Localization of nphp4 to Sertoli cells rather than germ cells reframes where the primary defect sits

Verdict

A competent mechanistic paper with a clear and interesting finding: the primary damage in nphp4-deficient testes starts in the somatic niche, not in sperm directly. That's a useful mechanistic insight. But this is a fish model with a non-mammalian spermatogenic architecture, and without a rescue experiment, the CRISPR results carry a residual caveat. Worth reading if you work on ciliopathy-linked infertility or testicular niche biology; not something that moves the needle on human clinical understanding yet.